Author details

Full Name

Christopher Chiu

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35123267	Immune checkpoint blockade in HIV.	EBioMedicine	2022
36465279	Single-cell genome-wide association reveals that a nonsynonymous variant in <i>ERAP1</i> confers increased susceptibility to influenza virus.	Cell Genom	2022
35029310	Innovative vaccine approaches-a Keystone Symposia report.	Ann N Y Acad Sci	2022
34711536	Resilience of the respiratory microbiome in controlled adult RSV challenge study.	European Respiratory Journal	2022
34586364	Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset.	JAMA Netw Open	2021
34289273	SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.	New England Journal of Medicine	2021
33692097	Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.	Sci Immunol	2021
33795879	Detection of respiratory syncytial virus defective genomes in nasal secretions is associated with distinct clinical outcomes.	Nat Microbiol	2021
34256007	Innate-like Gene Expression of Lung-Resident Memory CD8<sup>+</sup> T Cells during Experimental Human Influenza: A Clinical Study.	Am J Respir Crit Care Med	2021
33201806	Adaptive Multi-Channel Event Segmentation and Feature Extraction for Monitoring Health Outcomes.	IEEE Trans Biomed Eng	2021
33033192	Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection.	Science	2020
31815739	Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection.	J Clin Invest	2020
30753101	Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial.	American Journal of Respiratory and Critical Care Medicine	2019
31787986	Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs.	Frontiers in Immunology	2019
29552008	Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.	Frontiers in Immunology	2018
30356117	A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection.	Nat Commun	2018
28226227	Protective and Harmful Immunity to RSV Infection.	Annual Review of Immunology	2017
28502771	Metabolic Phenotypes of Response to Vaccination in Humans.	Cell	2017
29112746	Tuberculosis Infectiousness and Host Susceptibility.	J Infect Dis	2017
27889256	Controlled human infection with RSV: The opportunities of experimental challenge.	Vaccine	2017
27989626	Novel immunological insights in accelerating RSV vaccine development.	Vaccine	2017
27568914	Seasonal influenza vaccines and hurdles to mutual protection.	Clinical Microbiology and Infection	2016
26873992	Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.	Journal of Immunology	2016
26957359	Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.	Nat Commun	2016
25193634	B cell responses to influenza infection and vaccination.	Current Topics in Microbiology and Immunology	2015
25730467	Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.	American Journal of Respiratory and Critical Care Medicine	2015
25521681	Antiviral B cell and T cell immunity in the lungs.	Nature Immunology	2015
26687547	RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.	Nat Commun	2015
25157133	Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.	Proc Natl Acad Sci U S A	2014
24405366	Current concepts and progress in RSV vaccine development.	Expert Review of Vaccines	2014
24675761	Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.	PLoS Pathog	2014
23405860	Cross-reactive humoral responses to influenza and their implications for a universal vaccine.	Ann N Y Acad Sci	2013
23806514	Protective and dysregulated T cell immunity in RSV infection.	Current Opinion in Virology	2013
22615367	Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.	Proc Natl Acad Sci U S A	2012
19342630	A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.	Journal of Immunology	2009
16990607	Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo.	Blood	2007